仅可通过预约看房。请联系上市经纪人安排看房。
投资亮点：
• 91％已经出租的高质量机构办公室物业；优秀的到位现金流；加权平均剩余期限为4.3年
• 卓越的地理位置，位于I-270走廊/“DNA巷道”，毗邻国际标准与技术研究所、国立卫生研究院、美国国家癌症研究所总部和美国食品药物管理局。
• 确立的医学免疫租赁占地产租赁面积的71％；直接毗邻医学免疫全球总部；自2009年12月以来有三次单独的扩张
• 2012年6月（新月I）和2017年8月（新月II）完成了约翰·曼维尔热塑性聚烯烃屋顶系统，拥有20年保修期。
• MXD分区允许建筑面积比为0.75，这样可以在4.61英亩的土地上建造约150,000平方英尺
• 没有现有债务
投资概况：
新月I＆II（以下简称“物业”）由位于马里兰州盖瑟斯堡温德河巷道902号和904号的两栋单层写字楼组成，总面积达49,273平方英尺。该物业位于医学免疫全球总部的战略位置，距离270号州际公路有两英里，提供直达首都环城高速（495号州际公路）、郡际快道（ICC）和整个华盛顿特区大都市区的通道。
目前91％已经被租赁，平均剩余租期为4.3年，物业提供长期的安全的现金流。伦敦制药巨头阿斯特捷利康（NYSE：AZN和Moody's：A3）的研发部门医学免疫有限责任公司锚定该物业的租赁，占用该物业可租赁面积的71%，租约于2121年9月到期。
Financing Available. Please contact the listing broker - Bruce Strasburg at 202-533-2501 or bstrasburg@hfflp.com to inquire.
Property tours are available by appointment. Please contact the listing broker to schedule a tour.
Investment Highlights:
• 91% leased institutional quality office property; Excellent in-place cash flow; Weighted average remaining lease term of 4.3 years
• Outstanding location in I-270 Corridor / “DNA Alley” in close proximity to the National Institute of Standards and Technology, the National Institutes of Health, the National Cancer Institute Headquarters and the U.S. Food & Drug Administration
• Entrenched MedImmune tenancy, which occupies 71% of the Property’s rentable square feet; Directly adjacent to the MedImmune global headquarters; Three separate expansions since December 2009
• New Johns Manville TPO roof systems with 20 year warranties completed in June 2012 (Crescent I) and August 2017 (Crescent II)
• Zoning of MXD allows a floor to area ratio of 0.75, which offers the ability to build approximately 150,000 square feet on the 4.61 acre site
• Free & clear of existing debt
Investment Overview:
Crescent I & II (the “Property”) consists of two single story office buildings totaling 49,273 square feet located at 902 & 904 Wind River Lane in Gaithersburg, Maryland. The Property is strategically located adjacent to the MedImmune global headquarters and two miles from Interstate 270, which provides direct access to the Capital Beltway (Interstate 495), the Intercounty Connector (ICC) and the entire Washington, DC Metropolitan Area.
Currently 91% leased, with an average remaining lease term of 4.3 years, the Property provides long-term, secure cash flow. MedImmune, LLC, the research and development arm of London-based pharmaceutical giant AstraZeneca PLC (NYSE: AZN and Moody's: A3), anchors the Property’s tenancy, occupying 71% of the rentable square feet through September 2021. The tenant has demonstrated its commitment to the Property by expanding three separate times from its original occupancy in December 2009. Additionally, MedImmune has hosted a forums featuring representatives from other biotech companies, economic development groups and politicians to make Suburban Maryland one of the top three biotech hubs in the Nation by 2023.
This property will be auctioned on Tuesday, September 26 - Thursday, September 28 . The price displayed is the starting bid amount of $3,000,000. For information and to register to bid on this property, please visit Ten-X.com.
